Anti-Helicobacter pylori immunoglobulin G (IgG) and IgA antibody responses and the value of clinical presentations in diagnosis of Helicobacter pylori infection in patients with precancerous lesions

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

605

HTML

3116

Tables (1-4)

249

Sum=3970

Apr 15, 2003 (publication date) through Feb 21, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

H.Pylori

World J Gastroenterol. Apr 15, 2003; 9(4): 755-758
Published online Apr 15, 2003. doi: 10.3748/wjg.v9.i4.755

Table 1 The detected positive rates of H. pylori at different stages of CG

CAG, chronic atrophic gastritis; IM, intestinal metaplasia; DYS, dysplasia.

^aP < 0.05,

^bP < 0.01, mild IM vs severe IM; mild CAG vs. severe CAG.

Citation: Li S, Lu AP, Zhang L, Li YD. Anti-Helicobacter pylori immunoglobulin G (IgG) and IgA antibody responses and the value of clinical presentations in diagnosis of Helicobacter pylori infection in patients with precancerous lesions. World J Gastroenterol 2003; 9(4): 755-758
URL: https://www.wjgnet.com/1007-9327/full/v9/i4/755.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i4.755